Stay updated on Flamboyant 200/12 in Severe Asthma Adults Clinical Trial
Sign up to get notified when there's something new on the Flamboyant 200/12 in Severe Asthma Adults Clinical Trial page.

Latest updates to the Flamboyant 200/12 in Severe Asthma Adults Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe study record page now shows revision v3.6.5, replacing v3.6.4. This indicates a small update to the page's versioning or metadata rather than a change to the study data.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.6.4 as the current release, with Revision: v3.6.3 removed, indicating an update to the platform's software version.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.6.3 was added, replacing the previous v3.6.2. This reflects a page update without altering the study data or outcomes.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now displays Revision: v3.6.2 instead of v3.6.0, indicating a newer revision of the entry. This update does not change the study content or data presented on the page.SummaryDifference0.1%

- Check78 days agoChange DetectedNew help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting was adjusted. The page's revision/versioning text was updated to Revision: v3.6.0, and 'Last verified' and 'Last known status' lines were added to reflect recent validation and status information.SummaryDifference2%

- Check85 days agoChange DetectedRevision tag updated from v3.5.4 to v3.5.5, indicating a minor update to the study record. The change does not modify any study data, eligibility criteria, endpoints, or results.SummaryDifference0.1%

Stay in the know with updates to Flamboyant 200/12 in Severe Asthma Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flamboyant 200/12 in Severe Asthma Adults Clinical Trial page.